359 related articles for article (PubMed ID: 22100678)
1. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
Jabara R; Pendyala L; Geva S; Chen J; Chronos N; Robinson K
EuroIntervention; 2009 Dec; 5 Suppl F():F58-64. PubMed ID: 22100678
[TBL] [Abstract][Full Text] [Related]
2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
3. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
[TBL] [Abstract][Full Text] [Related]
4. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
Jabara R; Chronos N; Robinson K
Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
[TBL] [Abstract][Full Text] [Related]
5. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
Kume T; Waseda K; Koo BK; Yock PG; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Honda Y; Abizaid A; Fitzgerald PJ
Catheter Cardiovasc Interv; 2014 Jan; 83(1):19-24. PubMed ID: 23413202
[TBL] [Abstract][Full Text] [Related]
6. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
7. Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model.
Vassilev D; Gil R; Milewski K
EuroIntervention; 2011 Sep; 7(5):614-20. PubMed ID: 21930466
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography and intravascular ultrasound imaging of bioabsorbable magnesium stent degradation in porcine coronary arteries.
Slottow TL; Pakala R; Okabe T; Hellinga D; Lovec RJ; Tio FO; Bui AB; Waksman R
Cardiovasc Revasc Med; 2008; 9(4):248-54. PubMed ID: 18928950
[TBL] [Abstract][Full Text] [Related]
9. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
van der Giessen WJ; Sorop O; Serruys PW; Peters-Krabbendam I; van Beusekom HM
JACC Cardiovasc Interv; 2009 Apr; 2(4):284-90. PubMed ID: 19463438
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
[TBL] [Abstract][Full Text] [Related]
11. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
Abizaid A; Costa JR; Feres F
Catheter Cardiovasc Interv; 2011 Jan; 77(1):49-51. PubMed ID: 20506126
[TBL] [Abstract][Full Text] [Related]
12. A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis.
Orlik B; Buszman PP; Krauze A; Gąsior P; Desperak P; Pająk J; Kasperczyk J; Janas A; Jelonek M; Handzlik-Orlik G; Buszman PE; Milewski K
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):93-9. PubMed ID: 25944843
[TBL] [Abstract][Full Text] [Related]
13. Serial Evaluation of Vascular Response After Implantation of a New Sirolimus-Eluting Stent With Bioabsorbable Polymer (MISTENT): an optical coherence tomography and histopathological study.
Attizzani GF; Bezerra HG; Chamié D; Fujino Y; Spognardi AM; Stanley JR; Yamamoto H; Mehanna E; Wang W; Carlyle WC; McClain JB; Costa MA
J Invasive Cardiol; 2012 Nov; 24(11):560-8. PubMed ID: 23117309
[TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
15. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
16. First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial.
Ribeiro EE; Campos CM; Ribeiro HB; Lopes AC; Esper RB; Meirelles GX; Perin MA; Abizaid A; Lemos PA
EuroIntervention; 2014; 9(12):1380-4. PubMed ID: 24755382
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stent fracture detection by three-dimensional optical coherence tomography.
Okamura T; Matsuzaki M
Catheter Cardiovasc Interv; 2012 Mar; 79(4):628-32. PubMed ID: 21805594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
